Methods| Patients from 3 university hospitals who were enrolled beginning on March 23,
2021, in an ongoing observational cohort study on immune responses after 2 doses of mRNA …

Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …

Diagnostic assays currently used to monitor the efficacy of COVID-19 vaccines measure levels
of antibodies to the receptor-binding domain of ancestral SARS-CoV-2 (RBDwt). However…

B‐cell depletion induced by anti‐cluster of differentiation 20 (CD20) monoclonal antibody (mAb)
therapy of patients with lymphoma is expected to impair humoral responses to severe …

Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying
therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. …

Background Craniofacial resection (CFR) is still considered as the gold standard for managing
sinonasal malignancies of the anterior skull base (ASB), while endoscopic approaches …

Olfactory neuroblastoma (ONB) is a potentially curable disease, despite being an aggressive
malignancy with a poor natural history. Our goal was to evaluate management outcomes …

Objectives Sinonasal adenocarcinoma (AC) is a potentially curable disease despite being
an aggressive malignancy. Long-term survival can be achieved with early diagnosis and …

Objective Squamous cell carcinoma (SCC) of the paranasal sinuses is usually diagnosed at
an advanced stage, making curative therapy difficult. The goal of this study was to evaluate …

Background: Tumors originating from the craniofacial region usually present in a locally
advanced stage with frequent involvement of adjacent sites and have a strong tendency for local …